Form 8-K - Current report:
SEC Accession No. 0001193125-24-286866
Filing Date
2024-12-30
Accepted
2024-12-30 16:07:58
Documents
13
Period of Report
2024-12-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d917788d8k.htm   iXBRL 8-K 23031
  Complete submission text file 0001193125-24-286866.txt   147918

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prta-20241229.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prta-20241229_lab.xml EX-101.LAB 18690
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prta-20241229_pre.xml EX-101.PRE 11689
16 EXTRACTED XBRL INSTANCE DOCUMENT d917788d8k_htm.xml XML 3833
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 241589818
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)